The Globe and Mail

Malignant Ascites Clinical Trials, Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Clover Biopharmaceuticals

DelveInsight’s, “Malignant Ascites Pipeline Insight, 2025,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Malignant Ascites pipeline landscape. It covers the ...
The Globe and Mail

Ascites Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | YZY Biopharma, Healthgen Biotech, Grifols ...

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Ascites pipeline constitutes 10+ key companies continuously working towards developing 10+ Ascites treatment therapies, ...
ascopubs.org

Quality-of-life assessment in patients with malignant ascites: Results of a multicenter phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone.

Association between a validated symptom assessment tool and nurse clinical impression in patients with cancer admitted to a palliative care unit. This is an ASCO Meeting Abstract from the 2011 ASCO ...
Healthline

How Does Cirrhosis Cause Ascites?

Ascites is a common complication of cirrhosis. It happens due to the effects of portal hypertension and leads to fluid buildup in your abdomen. Ascites can be treated with medications, procedures, and ...
Mena FN

Ascites Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, And Key Companies Involved By Delveinsight | YZY Biopharma, Healthgen Biotech, Grifols Therapeutics ...

(MENAFN- GetNews) (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Ascites pipeline constitutes 10+ key companies continuously working towards developing 10+ Ascites ...